Professor and Head, Department of Medicinal Chemistry
Director, Institute for Therapeutics Discovery and Development
Robert Vince Endowed Chair and McKnight Presidential Chair
Drug Design and Development, Pharmacy
A world-renowned medicinal chemist, Georg’s goals are to discover and develop bioactive compounds and to improve their potency, selectivity, and pharmaceutical properties. Georg’s research interests include cancer, male contraception, and Alzheimer's disease. Dr. Georg is a co-inventor of Lusedra, a commercial anestetic drug. She is also a co-inventor of Gamendazole, a male contraceptive agent, and Minnelide an anticancer agent, both which are undergoing preclinical development.
Sources of Funding
National Institutes of Health